SHEHNAZ KANTHARIA

Self-motivated patient-centric physician-scientist with extensive leadership experience in clinical program and project management. Physician-scientist with 23years of expertise in clinical medicine, research, regulatory and strong leadership experience in people and product development. A proficient product and people development leader with strong interpersonal communication skills. Highly skilled in best practices, collaborations, and business development. Experienced in leading and training early-mid stage clinical and research professionals. Results-driven compassionate researcher focusing on patient education, preventive health, and improving quality of care using human-centered patient-focused designs. Have completed over 50 clinical research Oncology Trials at a Comprehensive Cancer Hospital near Baroda. Dedicated to being an impact player in clinical research.

• Supervised team of 12 staff members.
• Completed more than 50 Oncology Clinical Trials with large number of patients randomized

Indian Medical Association ( IMA )

Association of Otorhinolaryngologist of India ( AOI )

Foundation For Head and Neck Oncology ( FHNO )

Indian Society For Clinical Research ( ISCR )

www.linkedin.com/in/dr-shehnaz-kantharia-a8b85017

PUBLICATION

1.Uveal malignant melanoma: A case report; Acta Scientific Otolaryngology 4.6 (2022); 08-12.

2. Oral cavity reconstruction with pedicled and free flaps: a single institutional experience. Oncol J India. 2021; 5:60-6

3. Surgical audit of Head and Neck cancers in rural India. J Oncology and Cancer Screening. 2021;3(1).

4. Lymph node metastasis in cT1/T2 buccal mucosa squamous cell carcinoma: A subsite-specific study. Oncol J India 2021; 5:20-4

5.Impact of COVID-19 on cancer care in India: A cohort study. Lancet Oncol 2021; 22: 970–76

6.Oral cancer surgery and COVID-19 pandemic: Our initial experience. IP Indian J Anat and Surg of Head, Neck and Brain. 2021;7(1):22-25

7.Head and Neck Oncosurgery in the Extreme Elderly: Case Reports. Clin Case Rep Int. 2021; 5: 1209.

8.Conducting Clinical Research in A Comprehensive Cancer Centre in Rural India”. (2021). Clinical Research and Clinical Case Reports, 2(4); DOI: http;//doi.org/12.2021/1.1045

9.COVID-19 pandemic and oncology clinical trials – Our experience

10.Synovial Sarcoma of Buccal Mucosa: A Case Report. Clin Case Rep Int. 2021;5: 1229.

11.Image guided biopsy/FNAC in head and neck cancers in Covid-19 pandemic. IP Indian J Anat Surg Head Neck Brain 2021;7(2):51-53

12.Isolated 6th cranial nerve palsy-a rare manifestation of tuberculosis. Int J Otorhinolaryngol Head Neck Surg 2021;7:1365-8.

13.Role of HRCT Thorax in pre-operative assessment of RT-PCR COVID-19 negative oral cancer patients. J Radiol Oncol. 2020; 4: 008-011.

14.Parathyroid adenoma: a case report. Int J Otorhinolaryngol Head Neck Surg 2020;6:1533-7.

15.Head and Neck Schwannomas: Interesting Case Series with Review of Literature (Accepted and in the process of publishing in Journal of Medical Research and Surgery)

16.Survival and clinical outcomes of salvage surgery in recurrent oral cavity cancer- a single institution experience. (sent for publication in Indian journal of cancer on 12th February 2022 )

17.A rare anatomical star shaped branching pattern of Spinal Accessory Nerve: A case report with Review of Literature (sent for publication in IP Indian J Anat and Surg of Head, Neck and Brain on 14th July 2022)

18. Simultaneous local recurrence and second primary in the oral cavity with Review of Literature (sent for publication in Journal of Otolaryngology- ENT Research on 19th July 2022)

19.Imaging advances in oral cavity cancer and perspectives from a population in need: Consensus from the UK-India oral cancer imaging group. Journal of Head & Neck Physicians and Surgeons. 2021; 9(1) 4 – 12.

20.Integrated analysis of whole exome and RNA sequencing for Neo-epitope peptide prediction in buccal cancer. Canadian Journal of Biotechnology; Vol. 1, Iss. Special, (Dec 2017): 245. DOI:10.24870/cjb.2017-a230

21.Kitchen formulations in the management of oral cancer patients Inventi Impact: Neutraceutials,1:1,7-10,2010 Inventi Rapid: Neutraceutials, 1:1 2010 www.inventi.in 2010 ( ISSN 0976-4550)

22.Alveolar soft part sarcoma of the head and neck. Int J Oral Maxillofac Surg.. 2005 May;34(3):268-72. doi: 10.1016/j.ijom.2004.05.008.

TRAINING AND WORKSHOPS ORGANISED AND ATTENDED

· Organized Head and Neck Oncosurgery Conference, Surgical Workshop and CME at Goraj, 2006, 2008,2010,2011,2012, 2014, 2016 , 2018 as Joint Organising Secretary

· Organized Annual Conference of Foundation of Head And Neck Oncology (FHNO ) as Organising Secretary Dec 2023

· Organized GCP workshop in the year 2016 and 2018 KCHRC , Goraj

· Conducted training program on IEC Roles and Responsibilities on 05th July 2019

· Attended training program on Standard to be maintained by the Ethics Committee for accreditation on 05th July 2019

· Organised a one day training program on ICH-Good Clinical Practice and New Clinical Trial Guidelines 2019 on 7th Dec. 2019 at Kashiben Children’s Hospital, Baroda

Conducted one day training program on ICMR guidelines on 15th Feb.2020 at Kashiben

Children’s Hospital, Baroda

Conducted online GCP Training for Shankus Hospital Ethics Committee 2021, 2022